Cargando…

Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review

Detalles Bibliográficos
Autores principales: Rubatto, Marco, Merli, Martina, Avallone, Gianluca, Agostini, Andrea, Mastorino, Luca, Caliendo, Virginia, Barcellini, Amelia, Vitolo, Viviana, Valvo, Francesca, Fierro, Maria Teresa, Ribero, Simone, Quaglino, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359457/
https://www.ncbi.nlm.nih.gov/pubmed/36455565
http://dx.doi.org/10.18632/oncotarget.28265
_version_ 1784764142379335680
author Rubatto, Marco
Merli, Martina
Avallone, Gianluca
Agostini, Andrea
Mastorino, Luca
Caliendo, Virginia
Barcellini, Amelia
Vitolo, Viviana
Valvo, Francesca
Fierro, Maria Teresa
Ribero, Simone
Quaglino, Pietro
author_facet Rubatto, Marco
Merli, Martina
Avallone, Gianluca
Agostini, Andrea
Mastorino, Luca
Caliendo, Virginia
Barcellini, Amelia
Vitolo, Viviana
Valvo, Francesca
Fierro, Maria Teresa
Ribero, Simone
Quaglino, Pietro
author_sort Rubatto, Marco
collection PubMed
description
format Online
Article
Text
id pubmed-9359457
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-93594572022-08-09 Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review Rubatto, Marco Merli, Martina Avallone, Gianluca Agostini, Andrea Mastorino, Luca Caliendo, Virginia Barcellini, Amelia Vitolo, Viviana Valvo, Francesca Fierro, Maria Teresa Ribero, Simone Quaglino, Pietro Oncotarget Addendum Impact Journals LLC 2022-08-04 /pmc/articles/PMC9359457/ /pubmed/36455565 http://dx.doi.org/10.18632/oncotarget.28265 Text en Copyright: © 2022 Rubatto et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Addendum
Rubatto, Marco
Merli, Martina
Avallone, Gianluca
Agostini, Andrea
Mastorino, Luca
Caliendo, Virginia
Barcellini, Amelia
Vitolo, Viviana
Valvo, Francesca
Fierro, Maria Teresa
Ribero, Simone
Quaglino, Pietro
Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review
title Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review
title_full Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review
title_fullStr Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review
title_full_unstemmed Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review
title_short Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review
title_sort addendum: immunotherapy in xeroderma pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review
topic Addendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359457/
https://www.ncbi.nlm.nih.gov/pubmed/36455565
http://dx.doi.org/10.18632/oncotarget.28265
work_keys_str_mv AT rubattomarco addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview
AT merlimartina addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview
AT avallonegianluca addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview
AT agostiniandrea addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview
AT mastorinoluca addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview
AT caliendovirginia addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview
AT barcelliniamelia addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview
AT vitoloviviana addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview
AT valvofrancesca addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview
AT fierromariateresa addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview
AT riberosimone addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview
AT quaglinopietro addendumimmunotherapyinxerodermapigmentosumacaseofadvancedcutaneoussquamouscellcarcinomatreatedwithcemiplimabandaliteraturereview